Depression
IMB continues participation in European review of SSRIs, related antidepressants
Published in Biotech Business Week, January 3rd, 2005
The IMB considers that the current advice provided for these medicines is appropriate and their benefit/risk profile remains positive. The IMB will await the outcome of the E.U. review before implementing any further changes that may be recommended to update the product information for this group of medicines.
The IMB states that this group of medicines has received extensive scrutiny at national and E.U. level and that their use in the treatment of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Blood Brain Barrier
Contrast agent for central nervous system gets FDA approval - Cancer Therapy
Pivotal phase III trial to begin for new stem cell transplant drug candidate - Dura Substitute
U.S. FDA clears DuraMatrix Collagen Dura Substitute Membrane - Mergers & Acquisitions
Guilford to obtain exclusive worldwide ownership of AQUAVAN prodrug technology - Pulmonary Embolism
FDA grants clearance for Triage D-Dimer Test - Vein Graft Failure
Results reported from edifoligide phase III trial for peripheral bypass graft - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
